Kegg medicus dgroup
| DG02925 | |
| DG番号 | DG02925 |
| 分類 | DGroup |
| 名称 | CYP3A5 substrate TYPE Metabolism |
| ステム | - |
| 構造式 |  |
| メンバー | DG03072 Tenapanor D11652 Tenapanor (USAN/INN) D11653 Tenapanor hydrochloride (JAN/USAN) DG00103 Fenfluramine D07945 Fenfluramine (INN) D04148 Fenfluramine hydrochloride (JAN/USAN) D10263 Metformin hydrochloride and saxagliptin hydrochloride DG00119 Saxagliptin D08996 Saxagliptin (USAN/INN) D09753 Saxagliptin hydrate (JAN) D10262 Saxagliptin hydrochloride D03213 Apixaban (JAN/USAN/INN) DG00250 Guanfacine D08031 Guanfacine (INN) D00606 Guanfacine hydrochloride (JAN/USP) DG00478 Oxybutynin D00465 Oxybutynin (USAN/INN) D00722 Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP18) D11389 Dutasteride and tamsulosin D03820 Dutasteride (JAN/USP/INN) D10745 Ombitasvir, paritaprevir and ritonavir D09731 Crizotinib (JAN/USAN/INN) DG01414 Selumetinib D09666 Selumetinib (USAN/INN) D10024 Selumetinib sulfate (JAN/USAN) DG00715 Lapatinib D08108 Lapatinib (INN) D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN) D03218 Axitinib (JAN/USAN) DG00837 Naratriptan D08255 Naratriptan (INN) D00674 Naratriptan hydrochloride (JAN/USP) D11150 Cenobamate (USAN/INN) D04300 Ganaxolone (USAN/INN) D04641 Istradefylline (JAN/USAN/INN) D08969 Pimavanserin tartrate (USAN) D11022 Lemborexant (JAN/USAN/INN) DG00965 Vortioxetine D10184 Vortioxetine (USAN) D10185 Vortioxetine hydrobromide (JAN/USAN) D12544 Vortioxetine hemihydrobromide (USAN) D03215 Armodafinil (USAN/INN) DG02115 Valbenazine D10675 Valbenazine (USAN/INN) D10999 Valbenazine tosylate (USAN); Valbenazine tosilate (JAN) DG01119 Doxapram D07873 Doxapram (INN) D01872 Doxapram hydrochloride (USP); Doxapram hydrochloride hydrate (JP18) |
| 上位グループ | Metabolizing enzyme substrate |
| 注釈1 | - |
| 注釈2 | - |